Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
94.51
-1.99 (-2.06%)
At close: May 28, 2025, 4:00 PM
94.43
-0.08 (-0.08%)
After-hours: May 28, 2025, 4:00 PM EDT
Merit Medical Systems Employees
Merit Medical Systems had 7,400 employees as of December 31, 2024. The number of employees increased by 450 or 6.47% compared to the previous year.
Employees
7,400
Change (1Y)
450
Growth (1Y)
6.47%
Revenue / Employee
$187,616
Profits / Employee
$16,522
Market Cap
5.59B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
MMSI News
- 8 days ago - Merit Medical Acquires Biolife Delaware, L.L.C. - GlobeNewsWire
- 22 days ago - Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis - GlobeNewsWire
- 23 days ago - Merit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY® Arteriovenous Efficacy (WAVE) Trial - GlobeNewsWire
- 4 weeks ago - Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Merit Medical Launches the Ventrax™ Delivery System - GlobeNewsWire
- 7 weeks ago - Merit Medical Systems to Announce First Quarter 2025 Results on April 24, 2025 - GlobeNewsWire
- 2 months ago - Updated ASGE Clinical Practice Guideline Includes TIF 2.0 and cTIF for Management of GERD - GlobeNewsWire
- 2 months ago - Merit Medical Releases 12-Month Efficacy Results of the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE) - GlobeNewsWire